Airway responses to sequential challenges with platelet-activating factor and leukotriene D4 in rhesus monkeys.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of Laboratory and Clinical Medicine

• Publication date

  1984-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 6470563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The activity of aerosolized and intracutaneous synthetic platelet activating factor (AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys.

  1983cited by this paper
• Airway response to leukotriene D4 in rhesus monkeys.

  1983cited by this paper
• Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

  1983cited by this paper
• Comparative potency and pharmacology of isomers of leukotriene D4 on guinea-pig trachea: requirement for a 5(S)6(R) configuration.

  1982cited by this paper
• Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.

  1979cited by this paper
• The effect of histamine-1 and histamine-2 antagonists on airway responses to histamine in the rhesus monkey.

  1979cited by this paper
• Sequential immunologic stimuli to the respiratory tract: a paradox in the degree of potentiation of airway responses depending on the sequence of reverse passive and active immunologic stimulation.

  1977cited by this paper
• Acute airway obstruction in rhesus monkeys induced by pharmacologic and immunologic stimuli.

  1974cited by this paper

• AN AIRWAY HYPERRESPONSIVENESSMODEL IN RAT ALLERGIC ASTHMA

  2014cites this paper
• Airway Smooth Muscle in Asthma Symptoms: Culprit but Maybe Innocent

  2012influential citation
• Platelet-activating factor impairs mucociliary transport and increases plasma leukotriene 8 4 in man

  2012cites this paper
• Anti-allergic effects of natural tetranortriterpenoids isolated from Carapa guianensis Aublet on allergen-induced vascular permeability and hyperalgesia

  2005cites this paper
• Asthma Model Inflammation and Hyperreactivity in Mouse Factor-Acetylhydrolase Inhibits Airway Recombinant Human Platelet-Activating

  2000cites this paper
• Recombinant Human Platelet-Activating Factor- Acetylhydrolase Inhibits Airway Inflammation and Hyperreactivity in Mouse Asthma Model1

  2000cites this paper
• Pathological Aspects of Platelet-Activating Factor (PAF)

  1997cites this paper
• A bradykinin antagonist inhibits both bradykinin- and the allergen-induced airway response in primates.

  1997cites this paper
• Platelet activating factor compromises airway epithelial defense functions.

  1997cites this paper
• Biosynthetic Inhibitors and Receptor Antagonists to Platelet Activating Factor

  1997cites this paper
• Antigen-induced generation of lyso-phospholipids in human airways

  1996cites this paper
• Platelet-Activating Factor

  1995cites this paper
• Pulmonary iimmune ccells iin hhealth aand ddisease: the eeosinophil lleucocyte ((Part II)

  1994cites this paper
• Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part I).

  1994cites this paper
• Bimodal effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit.

  1994cites this paper
• Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.

  1993cites this paper
• The effect of platelet‐activating factor on the responsiveness of the human nasal airway

  1993cites this paper
• Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen.

  1993cites this paper
• Cytokines, platelet activating factor and eosinophils in asthma.

  1992cites this paper
• Effect of inhaled platelet-activating factor on bronchial inflammation in atopic non-asthmatic subjects.

  1992cites this paper
• Platelet-activating factor impairs mucociliary transport and increases plasma leukotriene B4 in man.

  1991cites this paper
• PAF antagonism as an approach to the treatment of airway hyperreactivity.

  1991cites this paper
• Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit

  1991cites this paper
• Inhibition of leukotriene biosynthesis and polymorphonuclear leukocyte functions by orally active quinolylmethoxyphenylamines.

  1991cites this paper
• Disubstituted tetrahydrofurans and dioxolanes and PAF antagonists.

  1991cites this paper
• Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.

  1991cites this paper
• Effect of azelastine and ketotifen on the bronchial and skin responses to platelet‐activating factor in humans

  1991cites this paper
• Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells.

  1991cites this paper
• Fibronectin levels in plasma after platelet-activating factor inhalation.

  1990cites this paper
• Does inhaled PAF cause airway hyperresponsiveness in humans?

  1990cites this paper
• EFFECTS OF OXATOMIDE ON BRONCHIAL HYPERRESPONSIVENESS IN CHILDHOOD ASTHMA

  1990cites this paper
• PAF-induced airway responses in sheep: effects of a PAF antagonist and nedocromil sodium.

  1990cites this paper
• Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man

  1990cites this paper
• Preclinical and clinical pharmacology of platelet‐activating factor receptor antagonists

  1990cites this paper
• Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects.

  1990cites this paper
• Effects of combined receptor antagonists of leukotriene D4 (LTD4) and platelet-activating factor (PAF) on rhesus airway responses to LTD4, PAF and antigen.

  1989cites this paper
• A PAF antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep.

  1989cites this paper
• Effect of platelet-activating factor inhalation on nonspecific bronchial reactivity in man.

  1989cites this paper
• The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves.

  1989cites this paper
• Influence of platelet-activating factor on leukotriene D4-induced contractions of the guinea pig parenchymal strip.

  1989cites this paper
• Platelet-activating factor and airway reactivity.

  1989cites this paper
• Eicosanoids and airway smooth muscle.

  1989cites this paper
• The use of the dose-response curve in the assessment of normal and asymptomatic asthmatic patients.

  1989cites this paper
• The synthesis, catabolism, and pathophysiological role of platelet-activating factor.

  1989cites this paper
• Animal models of asthma.

  1989cites this paper
• Chronological relationships between mediator release and changes in airway dynamics during an ascaris response in sensitive cynomolgus monkeys.

  1989cites this paper
• Interaction of inhaled LTC4 with histamine and PGD2 on airway caliber in asthma.

  1989cites this paper
• Platelet activating factor in pulmonary pathobiology.

  1989cites this paper
• Airway Epithelial Metabolism and Airway Smooth Muscle Hyperresponsiveness

  1989cites this paper
• Platelet-activating factor as a mediator of allergic disease.

  1988cites this paper
• Accumulation of platelets and eosinophils in baboon lung after paf-acether challenge. Inhibition by ketotifen.

  1988cites this paper
• Allergen-induced airway hyperresponsiveness.

  1988cites this paper
• Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.

  1988cites this paper
• Pharmacological Modulation of Platelet Activating Factor (PAF)‐induced Bronchoconstriction and Hypertension in Anaesthetized Guinea‐pigs

  1988cites this paper
• Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.

  1988cites this paper
• Bronchoconstriction induced by platelet-activating factor in the guinea pig and its inhibition by CV-3988, a PAF antagonist: serial changes in findings of lung histology and bronchoalveolar lavage cell population.

  1988cites this paper
• Evaluation of the effect of a platelet activating factor antagonist on platelet activating factor and Ascaris antigen-induced airway responses in rhesus monkeys.

  1987cites this paper
• Inflammatory mediator receptors and asthma.

  1987cites this paper
• Late asthmatic responses.

  1987cites this paper
• Structure-activity relationships of kadsurenone analogues.

  1987cites this paper
• Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor.

  1987cites this paper
• Pharmacologic analysis of 1-0-Alkyl-2-Acetyl-sn-Glycero-3-Phosphocholine-induced increases in cutaneous vascular permeability in the rat

  1987cites this paper
• Pathophysiology and pharmacology of asthma

  1987cites this paper
• Properties of PAF relevant to asthma.

  1987cites this paper
• Platelet-activating factor in late asthmatic response.

  1987cites this paper
• Lung endothelial and epithelial permeability after platelet-activating factor.

  1987cites this paper
• Pharmacology of ketotifen in asthma.

  1986cites this paper
• Aerosolized leukotriene D4 converts monkeys that are negative aerosolized ascaris responders to positive airway responders.

  1986cites this paper
• Pathobiology of platelet-activating factors.

  1986cites this paper
• Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man.

  1986cites this paper
• Inhibition of rhesus monkey airway and cutaneous responses to platelet-activating factor (PAF) (AGEPC) with the anti-PAF agent SRI 63-072.

  1986cites this paper
• Characterization of the airway response to inhaled leukotriene D4 in normal subjects.

  1986cites this paper
• Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma.

  1986cites this paper
• Pharmacology of aerosol leukotriene C4- and D4-induced alteration of pulmonary mechanics in anesthetized cynomolgus monkeys.

  1986cites this paper
• PAF and airway hyperreactivity.

  1985cites this paper
• Chapter 20. Platelet-Activating Factor: Multifaceted Biochemical and Physiological Mediator

  1985cites this paper
• Platelets and asthma.

  1985cites this paper
• Pharmacology of the late response to allergen and its relevance to asthma prophylaxis.

  1985cites this paper
• Chapter 10. Pulmonary and Antiallergy Agents

  1984cites this paper